Metacrine, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 62.21 million compared to USD 37.3 million a year ago. Basic loss per share from continuing operations was USD 2.29 compared to USD 3.97 a year ago.
1st Jan change | Capi. | |
---|---|---|
+23.54% | 48.09B | |
+46.90% | 40.62B | |
-2.70% | 40.43B | |
-6.20% | 28.36B | |
+8.31% | 24.89B | |
-20.18% | 19.01B | |
+29.06% | 12.09B | |
+0.08% | 11.88B | |
-0.85% | 11.8B |